Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Nov 23, 2023 6:47pm

280 Views

Post# 35750773

RE:RE:RE:RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

They are a bigger company on the NASDAQ and have a lot of pipelines on the go. They have trials going with Anktiva in a lot of different cancers so people are betting that the bladder approval will be the first of many.

Slick company. Lots of venture money to start. NASDAQ.....

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)